AI brief of an SEC Form 8-K · Commerce Bancshares (CBSH)

Commerce Bancshares approves buyback of up to 5 million shares, names new director

Neutral Impact 3 of 5 shareholder Written later

Commerce Bancshares' board approved a share repurchase of up to 5,000,000 total shares, combined with the amount remaining from an April 17, 2024 authorization. The filing does not give a dollar value or the remaining share count, and buybacks will be made at management's discretion and may be suspended or ended at any time. The board also appointed Alaina G. Maciá as an independent director effective October 31, 2025, to fill the seat vacated by Jonathan M. Kemper's retirement.

Key points

  • Board approved repurchase of up to 5,000,000 total shares, combined with the remaining amount from the April 17, 2024 authorization, announced in a November 3, 2025 press release
  • Repurchases may be made through open market or privately negotiated transactions, timing depends on market conditions, and the program may be suspended or terminated without notice
  • Alaina G. Maciá, CEO of MTM Health, appointed independent director effective October 31, 2025, filling the vacancy left by Jonathan M. Kemper's retirement and serving until 2027
  • Maciá will also serve on the Compensation and Human Resources Committee and receive prorated standard non-employee director compensation

The filing

CompanyCommerce Bancshares (CBSH)
Form8-K, current report
Filed with the SECNov 4, 2025, 4:07 PM ET
Accession number0000022356-25-000091

Items reported: 5.02 Director / Officer Change8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:57 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 04, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.